CVRx (CVRX) Cash Flow for Dividends: $0.00 Mil (TTM As of Mar. 2026)


CVRX CVRx Inc CVRX
57 GF Score
Price $5.86
GF Value $11.22
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is CVRx Cash Flow for Dividends?

CVRx CVRX +11.62% 57 Cash Flow for Dividends is $0.00 Mil as of Mar. 2026. GuruFocus rates CVRX with a GF Score™ of 57/100 and a GF Value™ of $11.22 (Possible Value Trap). The stock has 4 warning signs investors should review.

CVRx's cash flow for dividends for the three months ended in Mar. 2026 was $0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

CVRx Cash Flow for Dividends Related Terms

CVRx Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for CVRx's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVRx Cash Flow for Dividends Chart

CVRx Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

CVRx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CVRX
57GF Score
CVRx Inc CVRX
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVRx Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $0.00 Mil mean?
CVRx (CVRX) has a Cash Flow for Dividends of $0.00 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for CVRx and its competitors.
Is CVRx's Cash Flow for Dividends too high?
CVRx's current Cash Flow for Dividends is $0.00 Mil. Overall, CVRx has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CVRx's Cash Flow for Dividends compare to QTRX and SNWV?
CVRx's Cash Flow for Dividends of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for CVRx and its competitors. CVRx's current Cash Flow for Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVRx stock overvalued right now?
Based on GuruFocus' analysis, CVRx (CVRX) is currently considered Possible Value Trap. The stock's GF Value™ is $11.22, compared to a current price of $5.86 — trading 47.8% below its estimated fair value. The current Cash Flow for Dividends is $0.00 Mil. CVRx's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For CVRx (CVRX), the current Cash Flow for Dividends is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVRx (CVRX) Overvalued in 2026?

Based on GuruFocus' analysis, CVRx stock appears to be undervalued. The current stock price of $5.86 is trading 47.8% below its estimated GF Value™ of $11.22. GuruFocus considers CVRx to be Possible Value Trap.

Key valuation signals for CVRX:

  • Cash Flow for Dividends: $0.00 Mil
  • GF Value™: $11.22 vs. price of $5.86 (47.8% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the CVRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVRx Business Description

Address 9201 West Broadway Avenue, Suite 650, Minneapolis, MN, USA, 55445
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
57GF Score

Get the complete analysis for CVRX

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.86
Price
$11.22
GF Value